SOPs for Injectables V 2.0

The purpose of this SOP is to establish a standardized process for risk management throughout the product development lifecycle of sterile injectable formulations. The aim is to ensure early identification, assessment, control, and continuous monitoring of potential risks impacting product quality, safety, efficacy, compliance, and timelines.
Click to read the full article.

To establish a standard procedure for preparing, reviewing, storing, and managing documentation generated during the product development lifecycle of sterile injectable products. The SOP ensures consistency, traceability, and regulatory compliance in the documentation of formulation, analytical, and process development activities.
Click to read the full article.

To establish a standard methodology for the validation of sterilization cycles used in the manufacturing of sterile injectable products. This includes moist heat, dry heat, and gaseous sterilization procedures. The validation confirms cycle efficacy, equipment consistency, and compliance with cGMP, WHO, and ICH guidelines.
Click to read the full article.

To establish a standard and regulatory-compliant procedure for bulk filtration of injectable solutions in order to remove particulate and microbial contaminants prior to sterile filling. The procedure ensures integrity of the final product and compliance with GMP, WHO, and ICH guidelines.
Click to read the full article.

To define a standardized and GMP-compliant procedure for the purging of inert gases, such as nitrogen or argon, during the manufacturing of sterile injectable products. This process is critical to displace oxygen and moisture, preventing oxidation and maintaining the stability and sterility of sensitive products.
Click to read the full article.

To define the standard procedures for the sterile handling of ampoules during manufacturing of sterile injectable products, ensuring compliance with cGMP and minimizing the risk of contamination.
Click to read the full article.

This SOP outlines the procedures for sterile handling of ampoules during the manufacturing of injectable products. It ensures that all ampoules are handled in a contamination-free environment and are compliant with GMP and regulatory requirements.
Click to read the full article.

This SOP describes the standard procedures for operating the prefilled syringe (PFS) assembly line, ensuring all operations are performed under aseptic conditions with full compliance to GMP guidelines for sterile injectable products.
Click to read the full article.

To define the procedure for proper, accurate, and real-time documentation of all sterile batch manufacturing activities to ensure traceability, product quality, regulatory compliance, and audit readiness.
Click to read the full article.

To describe the validated procedure for the operation of Clean-In-Place (CIP) systems for cleaning vessels, transfer pipelines, filters, and other equipment used in sterile injectable manufacturing. This SOP ensures consistency, hygiene, and compliance with GMP.
Click to read the full article.